Skip to main content
Top
Published in: International Journal of Diabetes in Developing Countries 3/2011

01-09-2011 | Original Article

Depression in patients with diabetes mellitus and its impact on diabetes self-care, medication adherence and glycemic control

Authors: Firdous Jahan, Abdul Jabbar, Haider Naqvi, Safia Awan

Published in: International Journal of Diabetes in Developing Countries | Issue 3/2011

Login to get access

Abstract

Depression is an independent risk factor for the onset of type 2 diabetes. It negatively affects the course of diabetes and is associated with increased risk of complications, hyperglycemia, and mortality. Diabetes may exert its negative effect through hormonal, neuronal, or immune system changes that directly affect the body’s ability to produce or use insulin or, the effect of depression may be indirect, by resulting in poor self-care behavior, such as overeating, not exercising, skipping medication, or failing to keep medical appointments. Thus, identifying and treating depression in diabetes is strongly recommended. Cross-sectional study done in ambulatory care. A total of 320 diabetic patients who have duration of diabetes more than 1 year with out-patient diagnosis of diabetes (including fasting blood glucose >126 mg% twice in 1 year, random blood glucose >200 mg% twice in 1 year, currently taking any anti-diabetic agent, hospital discharge diagnosis of diabetes) were identified during the study period. Multivariable logistic regression was used to estimate odds ratio (Odds Ratios) and 95% confidence intervals (CIs). Overall depression was 17.5% (95% CI: 0.13–0.22%).The mean age was 55 ± 12 years, 138 (43%) were females. Hypertension 197(61.6%) and ischemic heart disease(IHD) (N = 68; 21.3%) were the most common co-morbidities. Factors independently associated with depression were; hypertension (OR 2.75; 95% CI: 0.99–7.37), complication of neuropathy (OR 4.56; 95% CI: 1.71–12.15) and nephropathy (OR 4.10; 95% CI: 1.26–13.33), family history of depression (OR 4.46; 95%CI: 1.50–13.26) and inadequate intake of fruit and vegetable (OR 0.32; 95% CI: 0.13–0.82). Depressed diabetics had more complications and sub-optimal self care. Coexistence of depression produced poor glycemic control.
Appendix
Available only for authorised users
Literature
1.
go back to reference Centers for Disease Control and Prevention. National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2007. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2008. Centers for Disease Control and Prevention. National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2007. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2008.
2.
go back to reference King H, Aubert RE, Herman WH. Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21:1414–31.PubMedCrossRef King H, Aubert RE, Herman WH. Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21:1414–31.PubMedCrossRef
4.
go back to reference American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2009;32:513–61. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2009;32:513–61.
5.
go back to reference Narayan KMV, Boyle JP, Geiss LS, Saaddine JD, Thompson TJ. Impact of recent increase in incidence on future diabetes burden. Diabetes Care. 2006;29:2114–6.PubMedCrossRef Narayan KMV, Boyle JP, Geiss LS, Saaddine JD, Thompson TJ. Impact of recent increase in incidence on future diabetes burden. Diabetes Care. 2006;29:2114–6.PubMedCrossRef
6.
go back to reference Golden SH, Lazo M, Carnethon M. Examining a bidirectional association between depressive symptoms and diabetes. JAMA. 2008;299:2751–9.PubMedCrossRef Golden SH, Lazo M, Carnethon M. Examining a bidirectional association between depressive symptoms and diabetes. JAMA. 2008;299:2751–9.PubMedCrossRef
7.
go back to reference Masaku K, Kalawale B, Mumec, et al. Depression, anxiety and quality of life among diabetic patients: a comparative study. J Natl Med Assoc J. 2008;100:73–8. Masaku K, Kalawale B, Mumec, et al. Depression, anxiety and quality of life among diabetic patients: a comparative study. J Natl Med Assoc J. 2008;100:73–8.
8.
go back to reference Das-Munshi J, Stewart R, Ismail K, et al. Screening for depression in patients with diabetes mellitus. Psychosom Med. 2008;70:869–74.CrossRef Das-Munshi J, Stewart R, Ismail K, et al. Screening for depression in patients with diabetes mellitus. Psychosom Med. 2008;70:869–74.CrossRef
9.
go back to reference Rahman A, Iqbal Z, Waheed W, et al. Translation and cultural adaptation of health questionnaire. JPMA. 2003;53:142–7. Rahman A, Iqbal Z, Waheed W, et al. Translation and cultural adaptation of health questionnaire. JPMA. 2003;53:142–7.
10.
go back to reference Gilmer TP, O’Connor PJ, Rush WA, Crain AL, Whitebird RR, Hanson AM, et al. Predictors of health care costs in adults with diabetes. Diabetes Care. 2005;28:59–64.PubMedCrossRef Gilmer TP, O’Connor PJ, Rush WA, Crain AL, Whitebird RR, Hanson AM, et al. Predictors of health care costs in adults with diabetes. Diabetes Care. 2005;28:59–64.PubMedCrossRef
11.
go back to reference Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med. 2000;160:3278–85.PubMedCrossRef Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med. 2000;160:3278–85.PubMedCrossRef
12.
go back to reference Mansour AA, Jabir MA. The prevalence of co morbid depression among adults with diabetes in Southern Iraq. Pak J Med Sci. 2007;23:185–7. Mansour AA, Jabir MA. The prevalence of co morbid depression among adults with diabetes in Southern Iraq. Pak J Med Sci. 2007;23:185–7.
13.
go back to reference Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care. 2001;24:1069–78.PubMedCrossRef Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care. 2001;24:1069–78.PubMedCrossRef
14.
go back to reference Onyike CU, Crum RM, Lee HB, Lyketsos CG, Eaton WW. Is obesity associated with major depression: results from the Third National Health and Nutrition Examination Survey. Am J Epidemiol. 2003;158:1139–47.PubMedCrossRef Onyike CU, Crum RM, Lee HB, Lyketsos CG, Eaton WW. Is obesity associated with major depression: results from the Third National Health and Nutrition Examination Survey. Am J Epidemiol. 2003;158:1139–47.PubMedCrossRef
15.
go back to reference Taj R, Siddiqui GR, Khan A, et al. Relationship between level of depression and psychological well-being among diagnosed diabetic and non-diabetic. Rawal Med J. 2005;30:65–7. Taj R, Siddiqui GR, Khan A, et al. Relationship between level of depression and psychological well-being among diagnosed diabetic and non-diabetic. Rawal Med J. 2005;30:65–7.
16.
go back to reference de Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ. Association of depression and diabetes complications: a meta-analysis. Psychosom Med. 2001;63:619–30.PubMed de Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ. Association of depression and diabetes complications: a meta-analysis. Psychosom Med. 2001;63:619–30.PubMed
17.
go back to reference Carney C. Diabetes mellitus and major depressive disorder: an overview of prevalence, complications, and treatment. Depress Anxiety. 1998;7:149–57.PubMedCrossRef Carney C. Diabetes mellitus and major depressive disorder: an overview of prevalence, complications, and treatment. Depress Anxiety. 1998;7:149–57.PubMedCrossRef
18.
go back to reference Egede LE. Diabetes major depression and functional disability among US adults. Diabetes Care. 2004;27:421–8.PubMedCrossRef Egede LE. Diabetes major depression and functional disability among US adults. Diabetes Care. 2004;27:421–8.PubMedCrossRef
19.
go back to reference Katon WJ, Russo JE, VonKorff M, et al. Long term effects on medical costs of improving depression out comes in patients with depression and diabetes. Diabetes Care. 2008;31:1155–9.PubMedCrossRef Katon WJ, Russo JE, VonKorff M, et al. Long term effects on medical costs of improving depression out comes in patients with depression and diabetes. Diabetes Care. 2008;31:1155–9.PubMedCrossRef
20.
go back to reference Lin EHB, Katon W, Von Korff M, et al. Relationship of depression and diabetes self care, medication adherence and prevention care. Diabetes Care. 2004;27:2154–60.PubMedCrossRef Lin EHB, Katon W, Von Korff M, et al. Relationship of depression and diabetes self care, medication adherence and prevention care. Diabetes Care. 2004;27:2154–60.PubMedCrossRef
21.
go back to reference Rush WA, Whitebird RR, Rush MR, et al. Depression in patients with diabetes: does it impact clinical goals? J Am Board Fam Med. 2008;21:392–7.PubMedCrossRef Rush WA, Whitebird RR, Rush MR, et al. Depression in patients with diabetes: does it impact clinical goals? J Am Board Fam Med. 2008;21:392–7.PubMedCrossRef
22.
go back to reference Williams Jr JW, Katon W, Unutzer J, et al. The effectiveness of depression care management on diabetes-related outcomes in older patients. Ann Intern Med. 2004;140:1015–24.PubMed Williams Jr JW, Katon W, Unutzer J, et al. The effectiveness of depression care management on diabetes-related outcomes in older patients. Ann Intern Med. 2004;140:1015–24.PubMed
23.
go back to reference Lustman PJ, Clouse RE. Practical considerations in the management of depression in diabetes. Diabetes Spectrum. 2004;17:160–6.CrossRef Lustman PJ, Clouse RE. Practical considerations in the management of depression in diabetes. Diabetes Spectrum. 2004;17:160–6.CrossRef
24.
go back to reference Fisher L, Skaff MM, Mullan JT, Arean P, Mohr D, Masharani U, et al. Clinical depression versus distress among patients with type 2 diabetes. Diabetes Care. 2007;30:542–8.PubMedCrossRef Fisher L, Skaff MM, Mullan JT, Arean P, Mohr D, Masharani U, et al. Clinical depression versus distress among patients with type 2 diabetes. Diabetes Care. 2007;30:542–8.PubMedCrossRef
25.
go back to reference Odegard PS, Gray SL. Barriers to medication adherence in poorly controlled diabetes mellitus. Diabetes Educat. 2008;34:692–7.CrossRef Odegard PS, Gray SL. Barriers to medication adherence in poorly controlled diabetes mellitus. Diabetes Educat. 2008;34:692–7.CrossRef
26.
go back to reference Katon WJ, Von Korff M, Ciechanowski P, Russo J, Lin EHB, Simon GE, Ludman E, Walker E, Bush T, Young B. Behavioral and clinical factors associated with depression among individuals with diabetes. 2004;27:914–20 Katon WJ, Von Korff M, Ciechanowski P, Russo J, Lin EHB, Simon GE, Ludman E, Walker E, Bush T, Young B. Behavioral and clinical factors associated with depression among individuals with diabetes. 2004;27:914–20
Metadata
Title
Depression in patients with diabetes mellitus and its impact on diabetes self-care, medication adherence and glycemic control
Authors
Firdous Jahan
Abdul Jabbar
Haider Naqvi
Safia Awan
Publication date
01-09-2011
Publisher
Springer-Verlag
Published in
International Journal of Diabetes in Developing Countries / Issue 3/2011
Print ISSN: 0973-3930
Electronic ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-011-0036-0

Other articles of this Issue 3/2011

International Journal of Diabetes in Developing Countries 3/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine